Table 3. Differential expression results for CRISPLD2 obtained from publicly available data of two previous microarray studies that investigated the effects of GCs on human ASM cells.

Study	Comparison Group	Rank	Adjusted P-value	Fold Change
GSE34313	4 hr DEX vs. baseline	305	5.1E-05	1.85
GSE34313	24 hr DEX vs. baseline	850	8.3E-06	1.95
GSE13168	Fluticasone vs. basal	6	3.9E-07	6.09
GSE13168	Fluticasone+EGF vs. EGF	4	2.4E-05	4.33
GSE13168	Fluticasone+IL1β vs. IL1β	45	1.5E-03	2.78
GSE13168	Fluticasone+EGF+IL1β vs. EGF+IL1β	68	3.9E-02	2.13

Rank refers to ranking within all differentially expressed genes of each comparison group.